Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services
Select solutions (2)
Active Filters (2)
Clear All
1 - 12 of 48 Results
Sort by:
Best Match

How CRISPR-based functional genomics is transforming drug discovery
Exploring how functional genomics is used in preclinical drug discovery with target identification, drug response mechanisms, and in vivo tumor biology.

Empowering T cell therapies: the strategic use of LentiBOOST in CAR T and TCR modalities
This literature review demonstrates how the LentiBOOST™ transduction enhancer can be applied to CAR T and TCR modalities.

Illuminating the path to innovation: Revvity's high content screening services
This scientific poster presented at ELRIG Drug Discovery introduces Revvity's preclinical high content imaging services.

Create your own Mimix reference standard
This flyer provides an overview of how Mimix controls for diagnostic workflows can be designed to customer requirements.

Mimix reference standards, latest products
This flyer provides an overview of the latest products from Mimix™ reference standards.

Effectiveness of CRISPR-Cas9 using pools of Dharmacon™ Edit-R™ synthetic crRNAs in high-content analysis screening experiments
Find out about the effectiveness of CRISPR-Cas9 using pools of Dharmacon™ Edit-R™ synthetic crRNAs in HCA screening experiments.

Pooled phenotypic CRISPR screening enables the identification of synergistic drug combinations for cancer therapy
This application note demonstrates how a pooled phenotypic CRISPR screening can be used to identify synergistic drug combinations for cancer therapy

Linking genes to phenotypes with CRISPR screening
Literature review on the multiple CRIPSR screening techniques available for drug discovery and their benefits.

Overcoming hurdles in high-throughput profiling of cancer cell responses
Presenting case studies on how functional genomic screening is used to find therapeutic targets, identify patient populations, uncover MoA, investigate drug combinations, and reveal drug resistance and sensitivity

CRISPR-Cas9 screening: a powerful approach to advance drug discovery
Find out about the potential of CRISPR-Cas9 screening for drug discovery in this white paper.

wbs-leveraging-multiplatform-cell-based-screening-for-target-id
Learn about how to leverage multiplatform cell-based screening for target ID in this on-demand webinar.


Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.